1,2,4,5-Tetraoxane Conjugates as a Novel Ferrous Iron-Activatable Platform for Targeted Tumor Drug Delivery
Year: 2026
Type: article
Institutions: University of Lisbon, University of California, San Francisco
Language: English
Subfield: Biomaterials
Field: Materials Science
Domain: Physical Sciences
Open Access status: closed
Awards: Instituto de Investigação do Medicamento, G1709334129, Innovative therapies and technologies in cancer, Innovative therapies and technologies in cancer, Instituto de Investigação do Medicamento, Conjugados de Fármacos Ativaveis por Ião Ferroso: Alvejar o Metabolismo do Ferro na Era da Oncologia de Precisão, G3372274971, TRANSLATING RIPK3 SIGNALLING INTO APPLICATION IN METABOLIC LIVER DISEASE, ONCOLOGIA DE PRECISÃO: TERAPIAS E TECNOLOGIAS INOVADORAS, Tetraoxane-based tumor-activated prodrug strategy to target intracellular labile ferrous iron, Tetraoxane-based tumor-activated prodrug strategy to target intracellular labile ferrous iron, Instituto de Investigação do Medicamento, G9001397187
OpenAlex ID: W7236133743
